Strata Critical Medical, Inc. (SRTA) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $449.51M | Exchange | NASDAQ |
| Sector | Industrials | Industry | Airlines, Airports & Air Services |
| Country | US | CEO | Melissa Tomkiel |
| IPO Date | 2019-11-05 | CAGR | 35.97% |
| Employees | 327 | Website | www.stratacritical.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $397.29M | P/E | -24.49 | Forward P/E | — | PEG | — |
| P/S | 2.24 | P/B | 2.02 | P/CF | -18.38 | P/FCF | -12.95 |
| Sales | $255.97M | Sales 1Y | 0.64% | Sales 3Y | 34.64% | Sales 5Y | 774.95% |
| EPS | $-0.21 | EPS 1Y | 3.42% | EPS 3Y | -63.8% | EPS 5Y | -48.18% |
| Sales QoQ | 7.6% | EPS QoQ | -533.21% | Sales QoQ Avg | 3.4% | EPS QoQ Avg | -119.57% |
| Gross Margin | 20.56% | Operating Margin | -7.97% | Profit Margin | 15.71% | ROCE | -7.11% |
| ROA | 12% | ROE | 14% | Altman Z Score | 5.05 | Piotroski Score | 2 |
| Current Ratio | 2.64 | Quick Ratio | 2.64 | Cash Ratio | 0.36 | Op. CF Ratio | 0.12 |
| Debt/Equity | 0.02 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.01 | Lt Debt/Cap. | 0.01 |
| Intrst Cov. | — | Inventory Turnover | — | Asset Turnover | 0.77 | Receivables Turnover | 5.9 |
| Enterprise Value | $397.29M | P/E Ratio | -24.49 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 2.24 | P/B Ratio | 2.02 |
| P/CF Ratio | -18.38 | P/FCF Ratio | -12.95 |
| EPS | $-0.21 | EPS Growth 1Y | 3.42% |
| EPS Growth 3Y | -63.8% | EPS Growth 5Y | -48.18% |
| Revenue Growth 1Y | 0.64% | Gross Margin | 0.21% |
| Operating Margin | -0.08% | Profit Margin | 0.16% |
| ROE | 0.14% | ROA | 0.12% |
| ROCE | -0.07% | Current Ratio | 2.64 |
| Quick Ratio | 2.64 | Cash Ratio | 0.36 |
| Debt/Equity | 0.02 | Interest Coverage | — |
| Altman Z Score | 5.05 | Piotroski Score | 2 |
Strata Critical Medical, Inc. (SRTA) valuation & financials
Strata Critical Medical, Inc. (SRTA) has a market capitalization of $449.51M and trades at a price-to-earnings ratio of -24.5. It operates in the Industrials sector (Airlines, Airports & Air Services).
Strata Critical Medical, Inc.'s revenue grew +0.6% over the last year.
Strata Critical Medical, Inc.'s next earnings report is scheduled for November 9, 2026 before market open; analysts estimate EPS of $0.01. Check the earnings calendar to see all companies reporting this week.
Strata Critical Medical, Inc. (SRTA) — frequently asked questions
When does Strata Critical Medical, Inc. (SRTA) report earnings next?
Strata Critical Medical, Inc. is expected to report earnings on November 9, 2026 before market open. Analysts estimate EPS of $0.01.
What is Strata Critical Medical, Inc.'s market cap?
Strata Critical Medical, Inc. (SRTA) has a market capitalization of $449.51M.
What is SRTA's P/E ratio?
Strata Critical Medical, Inc. trades at a price-to-earnings ratio of -24.5, with trailing twelve-month EPS of $-0.21.
How fast is Strata Critical Medical, Inc. growing?
Strata Critical Medical, Inc.'s revenue grew +0.6% over the last year.
Compare with other Industrials companies: Caterpillar (CAT) · General Electric (GE) · Raytheon Technologies (RTX) · Siemens (SIE.DE) · CATL (300750.SZ) · Schneider Electric (SU.PA)